Semax Nasal Spray

Semax Nasal Spray

Nasal Spray · 30mg · 0.3% (3mg/mL)

$59.99

Certificate of Analysis

Sample
BatchHLM-SMX-2026-001
Purity99.2
MethodHPLC + LC-MS/MS
LabJanoshik Analytical

Sample COA shown. Batch-specific verified results replace this document once the first production batch is received and tested by Janoshik Analytical.

View SampleCOA →

Certificate of Analysis

Full Test Results

CompoundSemax
SequenceMet-Glu-His-Phe-Pro-Gly-Pro
Molecular FormulaC37H51N9O10S
Molecular Weight813.93 g/mol
CAS Number80714-61-0
Batch NumberHLM-SMX-2026-001
Purity99.2%
Testing MethodHPLC + LC-MS/MS
LaboratoryJanoshik Analytical
FormNasal Spray
Concentration0.3% (3mg/mL)
Total Peptide30mg
Volume10mL

Semax (MEHFPGP) is a synthetic heptapeptide derived from the adrenocorticotropic hormone (ACTH) fragment 4–10, stabilized with a C-terminal Pro-Gly-Pro tripeptide to enhance enzymatic resistance. In preclinical research, Semax has been studied for its interactions with melanocortin receptors and its potential to upregulate brain-derived neurotrophic factor (BDNF) expression, supporting investigations into neuroplasticity, cognitive function, and neuroprotection. Each bottle delivers 30mg of research-grade Semax in a 10mL metered nasal spray (3mg/mL, ~300mcg per actuation). Purity verified at ≥99% via HPLC and identity confirmed by LC-MS/MS. Third-party tested by Janoshik Analytical. For research use only — not for human consumption.

For research use only — not for human consumption.

This product is not intended to diagnose, treat, cure, or prevent any disease. This statement has not been evaluated by the FDA.

Also Available